Groundbreaking data tool may uncover novel class of GPCRs 27 October 2021 | By Anna Begley (Drug Target Review) A new computer-aided tool maps allosteric sites in G protein-coupled receptors to search for allosteric drugs to treat a range of diseases.
Experimental mouse model reveals potential progeria treatment strategy 27 October 2021 | By Anna Begley (Drug Target Review) Scientists have found that Hutchinson-Gilford Progeria Syndrome (HGPS) can be prevented with treatments targeting the cardiovascular system using a novel mouse model.
Specific mechanism found to control transition from acute to chronic pain 27 October 2021 | By Anna Begley (Drug Target Review) A new study is the first to identify N-acylethanolamine acid amidase as a new drug target to treat different forms of chronic pain.
Gene therapy shows promise for Angelman syndrome treatment 26 October 2021 | By Anna Begley (Drug Target Review) A new gene therapy restored motor skill-learning and usual behaviours in Angelman syndrome mouse models, suggesting a novel therapy for the condition.
PANACEA consortium to increase global access to NMR spectroscopy 26 October 2021 | By Anna Begley (Drug Target Review) The Pan-European Solid-State NMR Infrastructure for Chemistry-Enabling Access will offer researchers access to over 30 NMR spectrometers.
Molecular targets for breast cancer relapse identified in new study 26 October 2021 | By Anna Begley (Drug Target Review) German, Norwegian and British scientists have identified molecular targets for therapies that could prevent breast cancer recurrence.
$2.6 million granted to create pan-coronavirus vaccine 25 October 2021 | By Anna Begley (Drug Target Review) The La Jolla Institute for Immunology and Brigham and Women's Hospital will collaborate to develop a pan-coronavirus vaccine.
Novel strategy successfully suppresses HIV infection in mice 25 October 2021 | By Anna Begley (Drug Target Review) A new method, called synapse for T-cell activation (synTac), can attack HIV-infected T cells and may be a new cure for HIV and other diseases.
Targeting channel in cell lysosome could selectively kill cancer cells 25 October 2021 | By Anna Begley (Drug Target Review) Activating the protein channel TRPML1 induced selective melanoma cell death while sparing normal cells, suggesting a potential pathway for new cancer therapies.
Nanofibre platform shows potential for inhibiting brain tumour growth 22 October 2021 | By Anna Begley (Drug Target Review) Scientists have created a nanofibre-based sheet to control and direct the migration of cells, possibly leading to brain tumour therapies.
$7.5 million to fund senescent cell research for age-related disease 22 October 2021 | By Anna Begley (Drug Target Review) Washington University will receive $7.5 million from the NIH to study senescent cells for treatments against age-related diseases.
Algorithm identifies cancer drugs to treat pulmonary hypertension 21 October 2021 | By Anna Begley (Drug Target Review) Scientists have identified potential cancer drugs to treat pulmonary hypertension using experimental and computational approaches.
MIT study reveals how lipid imbalance affects cancer growth in mice 21 October 2021 | By Anna Begley (Drug Target Review) In a new study, a calorie-restricted diet significantly reduced tumour growth in mouse models, suggesting new possibilities for cancer therapies.
Novel method refines cryogenic electron microscopy (cyro-EM) 21 October 2021 | By Anna Begley (Drug Target Review) The statistical method known as maximum entropy could improve cryogenic electron microscopy (cryo-EM) for more effective drug treatments.
New antibiotic a possible alternative to treat Lyme disease 20 October 2021 | By Anna Begley (Drug Target Review) The antimicrobial hygromycin A was shown to clear Lyme disease in mice, representing a promising therapeutic against the disease.
